PTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm Sellers

PTC Therapeutics Inc. (NASDAQ:PTCT) shares are tumbling on Wednesday, after the company reported topline results from the 24-month interim analysis of its PIVOT-HD long-term extension study.